New immunotherapy improves MS symptoms

Nov 20, 2018
A world–first clinical trial of a new cellular immunotherapy for multiple sclerosis (MS) has improved symptoms and quality of life for the majority of patients.

Other news

Cookies help us deliver our services. By using our services, you agree to our use of cookies.